The state of drug price transparency and its impact on patient access

Join your fellow drug manufacturing leaders and Turquoise Health President Chris O'Dell for a closed-door discussion on the current and future state of drug price transparency legislation. Together, we’ll explore how manufacturers are using transparency data to strengthen market access strategies, improve patient affordability, and navigate a rapidly evolving reimbursement landscape.

‍

‍

‍